UPM Raflatac fights against counterfeit drugs with new pharma security label materials
(UPM, Helsinki, 27 February 2019 at 11:00 EET) - UPM Raflatac is expanding its range of labeling solutions to support pharmaceutical companies in improving patient safety through secure and tamper-evident packaging. These solutions offer an easy route to achieving full compliance with the EU Falsified Medicines Directive on packaging for prescription drugs and high-risk, over-the-counter medicines. With tamper-evident labeling patients can be sure that their pharmaceutical products are authentic and have not been tampered with. UPM Raflatac's solutions work with pharmaceutical